LeMaitre Vascular Reports Strong Q4 Results, Boosts Dividend 25%, and Authorizes $100M Share Buyback
LMAT sits 28% above its 52-week low of $71.42.
Summary
LeMaitre Vascular reported strong Q4 2025 financial results, provided optimistic 2026 guidance, increased its quarterly dividend by 25%, and authorized a new $100 million share repurchase program.
Key Events · Earnings and Guidance · LMAT
-
Strong Q4 2025 Financial Performance
The company reported Q4 2025 sales of $64.5 million, a 16% increase year-over-year, with operating income surging 47% to $18.8 million and diluted EPS rising 39% to $0.68. Cash also increased by $16.1 million sequentially to $359.1 million.
-
Positive 2026 Financial Guidance
LeMaitre Vascular provided optimistic full-year 2026 guidance, projecting sales between $276 million and $284 million (midpoint $280 million, +12%) and adjusted operating income between $75.0 million and $80.7 million (midpoint $77.8 million, +21%).
-
Significant Quarterly Dividend Increase
The Board of Directors approved a 25% increase in the quarterly dividend, raising it to $0.25 per share of common stock, payable on March 26, 2026.
-
New Share Repurchase Authorization
The Board authorized a new share repurchase program of up to $100.0 million of the company's common stock, valid until February 18, 2027.
Analysis · LMAT · Industrial Applications And Services
This 8-K filing signals robust financial health and strong management confidence. The company delivered impressive Q4 2025 results, significantly exceeding prior year performance across key metrics like sales, operating income, and EPS. The positive momentum is projected to continue into 2026 with solid guidance. Furthermore, the 25% dividend increase and the authorization of a substantial $100 million share repurchase program demonstrate a commitment to returning value to shareholders and suggest management believes the stock is undervalued. These combined actions are highly positive and likely to be viewed favorably by the market.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 40.7% of the 388 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.42%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LMAT was trading at $91.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $71.42 to $105.55. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.